Globus Medical (GMED) is a Healthcare · Medical Devices company listed on NYSE. Price $74.33 (+0.23%), Market cap $10.85B, P/E ratio 18.68, 52-week low–high $51.89 ~ $96.82.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstructio
Financial statements, price targets, institutional (13F) holdings and related news for Globus Medical are updated in real time on BlackAll Trade.
Globus Medical trades at $74.33 (+0.23%). Real-time quotes and charts are available on BlackAll Trade.
Globus Medical has a market cap of about $10.85B. Its P/E ratio is 18.68.
Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising